Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis.
Grönberg C, Rattik S, Tran-Manh C, Zhou X, Rius Rigau A, Li YN, Györfi AH, Dickel N, Kunz M, Kreuter A, Matei EA, Zhu H, Skoog P, Liberg D, Distler JH, Trinh-Minh T.
Grönberg C, et al. Among authors: kunz m.
Ann Rheum Dis. 2024 Apr 9:ard-2023-225158. doi: 10.1136/ard-2023-225158. Online ahead of print.
Ann Rheum Dis. 2024.
PMID: 38594058
Free article.